Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
20 September 2022 Research identifies new treatment target for CNS injury and neurological disease Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.
12 July 2022 Research shows investigational drug fosters nerve repair after injury Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug can foster regeneration of damaged nerves after spinal trauma
04 July 2022 Largest genetic atlas for zebrafish ‘breakthrough’ for biomedical research A collection of genetic maps will enable scientists to better study key health conditions including cancers and heart disease.
15 March 2022 COVID-19 vaccination study opens at Great Ormond Street Hospital Patients at Great Ormond Street Hospital and Southampton Children's Hospital are taking part in research to work out how they respond to COVID-19 vaccination.
03 March 2022 Researchers find genetic 'fingerprints' of ancient migrations in modern-day United Arab Emirates Geneticists and archaeologists analysed 1,200 people from the United Arab Emirates and found genetic traces of population mixing spanning thousands of years.
16 February 2022 World-leading surgical research team gets fresh funding to save lives A world-leading global surgical research team led by the University of Birmingham has received £7 million to continue life-saving work in developing countries.